McDonaldWICompstonDAEdanG, et al. Recommended diagnostic criteria for multiple sclerosis: Guidelines from the international panel on the diagnosis of multiple sclerosis. Ann Neurol2001; 50: 121–127.
2.
PolmanCHReingoldSCEdanG, et al. Diagnostic criteria for multiple sclerosis: 2005 revisions to the McDonald criteria. Ann Neurol2005; 58: 840–846.
3.
PolmanCHReingoldSCBanwellB, et al. Diagnostic criteria for multiple sclerosis: 2010 revisions to the McDonald criteria. Ann Neurol2011; 69(2): 292–302.
4.
ThompsonABanwellBBarkoffF, et al. Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria. Lancet Neurol2018; 17(2): 162–173.
5.
MontalbanXLebrun-FrenayCOhJ, et al. Diagnosis of multiple sclerosis: 2024 revisions of the McDonald criteria. Lancet Neurol2025; 24(10): 850–865.
6.
BarkhofFReichDSOhJ, et al. MAGNIMS-CMSC-NAIMS consensus recommendations on the use of MRI for the diagnosis of multiple sclerosis. Lancet Neurol2025; 24(10): 866–879.
7.
SaidhaSGreenALeocaniL, et al. The use of optical coherence tomography and visual evoked potentials in the 2024 McDonald diagnostic criteria for multiple sclerosis. Lancet Neurol2025; 24: 880–892.
8.
DeisenhammerFHegenHArrambideG, et al. Positive cerebrospinal fluid in the 2024 McDonald criteria for multiple sclerosis. eBioMedicine DOI: 10.1016/j.ebiom.2025.105905. https://doi.org/10.1016/j.ebiom.2025.105905
9.
KuhlmannTMocciaMCoetzeeT, et al. Multiple sclerosis progression: Time for a new mechanism-driven framework. Lancet Neurol2023; 22(1): 78–88.
10.
TremlettHMungerKLMakhaniN. The multiple sclerosis prodrome: Evidence to action. Front Neurol2022; 12: 761408.
